Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Researcher In Plan B Survey Supports Removing Age Restriction

This article was originally published in The Tan Sheet

Executive Summary

The safety record of emergency contraceptive Plan B supports removing age restrictions on sales of the product, according to Rebekah E. Gee, the lead researcher behind a survey on access to the drug and an advocate for women's access to reproductive medicine
Advertisement

Related Content

Restoring Confidence Should Be FDA Commissioner’s Top Priority – Nissen
Restoring Confidence Should Be FDA Commissioner’s Top Priority – Nissen
Restoring Confidence Should Be FDA Commissioner’s Top Priority – Nissen
BTC Proponents Cite Pharmacists’ Role; Opponents Question Need
Plan B Pioneers OTC “Pharmacy Counter” Approval, Dual-Status Marketing
Plan B Pioneers OTC “Pharmacy Counter” Approval, Dual-Status Marketing

Topics

Advertisement
UsernamePublicRestriction

Register

PS102390

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel